Mitochondrial nanotunnels in cardiac disorders
4 affiliations
- 1Department of Surgery, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, China
- 2College of Veterinary Sciences & Animal Husbandry, Abdul Wali Khan University Mardan, Khyber Pakhtunkhwa, Pakistan
- 3Hong Kong Hub of Paediatric Excellence (HK HOPE), Hong Kong Children's Hospital (HKCH), Hong Kong, China
- 4Kunming Institute of Zoology-The Chinese University of Hong Kong (KIZ-CUHK) Joint Laboratory of Bioresources and Molecular Research of Common Diseases, Hong Kong, China
Abstract
Mitochondria are essential double-membraned organelles that provide most of the adenosine triphosphate (ATP) required for cardiac contraction and ion homeostasis. Beyond energy production, they regulate Ca2+ handling, reactive oxygen species (ROS) signaling, redox balance, and cell survival. Consequently, mitochondrial dysfunction is widely recognized as a central mechanism underlying cardiac disorders, while altered mitochondrial dynamics—the ability of mitochondria to change shape and connectivity—has been associated with diverse myocardial diseases. Yet, the conventional fusion-fission paradigm does not adequately explain how mitochondria, constrained within the rigid sarcomeric lattice of cardiomyocytes, maintain function and quality control. In this highly ordered environment, mitochondrial subpopulations are densely packed and largely immobilized, limiting long-range organelle transport. Recent ultrastructural studies have identified thin double-membrane nanotunnels as potential conduits for communication between distant mitochondria. Experimental studies have identified mitochondrial nanotunnels (MNTs) in cardiomyocytes and reported changes in their abundance or associated communication in selected cardiac models. However, their contribution to metabolic and stress signaling remains incompletely defined. Despite these intriguing observations, the precise role of nanotunnels across cardiac disorders remains uncertain. Key questions include whether their activity is protective or detrimental, how they behave across distinct mitochondrial subpopulations, and whether they contribute to adaptive or maladaptive remodeling under stress. Addressing these gaps is critical for understanding how mitochondrial networks respond to injury. This review brings together current knowledge on cardiac mitochondrial architecture, fusion-fission dynamics, nanotunnel structure and biogenesis, and their potential involvement in cardiac disorders, while highlighting current methodological limitations. Recent studies suggest that nanotunnels are more than passive structural features; they may represent functional pathways for metabolic and signaling integration within the constrained cardiac environment. Mitochondrial nanotunnels may represent potential therapeutic targets once their causal and context-dependent roles in cardiac disorders have been established.
Related
- Cardiomyocyte-specific deletion of thioredoxin promotes myocardial injury, infarction and mitochondrial dysfunction: translocation of cytosolic thioredoxin into mitochondria rescue myocardial dysfunction by restoration of cardiac mitochondrial structure and function.
- Mitochondrial heterogeneity across cardiac cell types in heart failure with preserved ejection fraction
- MCT1-dependent mitochondrial lactate import sustains cardiac metabolism
- The "Invisible Killer” of Neurodegeneration: Mitochondrial Dysfunction in Neurodegenerative Disorders, Mechanisms, Emerging Pathways and Therapeutic Strategies
- Phosphorylation of the mitochondrial calcium uniporter beta subunit matrix domain locks a conformation that suppresses mitochondrial calcium flux
BibTeX
@article{gu2026mitochondrial,
title = {{Mitochondrial nanotunnels in cardiac disorders}},
author = {Qian Gu and Attaur Rahman and Sang-Bing Ong and Randolph H. L. Wong},
journal = {Annals of Translational Medicine},
year = {2026},
month = oct,
doi = {10.21037/atm-2026-0151},
url = {https://doi.org/10.21037/atm-2026-0151},
note = {CC BY-NC-ND 4.0},
}
RIS
TY - JOUR
TI - Mitochondrial nanotunnels in cardiac disorders
AU - Qian Gu
AU - Attaur Rahman
AU - Sang-Bing Ong
AU - Randolph H. L. Wong
PY - 2026
DA - 2026/10/24
JO - Annals of Translational Medicine
DO - 10.21037/atm-2026-0151
UR - https://doi.org/10.21037/atm-2026-0151
AB - Mitochondria are essential double-membraned organelles that provide most of the adenosine triphosphate (ATP) required for cardiac contraction and ion homeostasis. Beyond energy production, they regulate Ca2+ handling, reactive oxygen species (ROS) signaling, redox balance, and cell survival. Consequently, mitochondrial dysfunction is widely recognized as a central mechanism underlying cardiac disorders, while altered mitochondrial dynamics—the ability of mitochondria to change shape and connectivity—has been associated with diverse myocardial diseases. Yet, the conventional fusion-fission paradigm does not adequately explain how mitochondria, constrained within the rigid sarcomeric lattice of cardiomyocytes, maintain function and quality control. In this highly ordered environment, mitochondrial subpopulations are densely packed and largely immobilized, limiting long-range organelle transport. Recent ultrastructural studies have identified thin double-membrane nanotunnels as potential conduits for communication between distant mitochondria. Experimental studies have identified mitochondrial nanotunnels (MNTs) in cardiomyocytes and reported changes in their abundance or associated communication in selected cardiac models. However, their contribution to metabolic and stress signaling remains incompletely defined. Despite these intriguing observations, the precise role of nanotunnels across cardiac disorders remains uncertain. Key questions include whether their activity is protective or detrimental, how they behave across distinct mitochondrial subpopulations, and whether they contribute to adaptive or maladaptive remodeling under stress. Addressing these gaps is critical for understanding how mitochondrial networks respond to injury. This review brings together current knowledge on cardiac mitochondrial architecture, fusion-fission dynamics, nanotunnel structure and biogenesis, and their potential involvement in cardiac disorders, while highlighting current methodological limitations. Recent studies suggest that nanotunnels are more than passive structural features; they may represent functional pathways for metabolic and signaling integration within the constrained cardiac environment. Mitochondrial nanotunnels may represent potential therapeutic targets once their causal and context-dependent roles in cardiac disorders have been established.
SN - 2305-5839
SN - 2305-5847
ER -